Understanding people who have never received HIV medical care: A population-based approach

Public Health Reports

Volumn 125, Issue 4, 2010, Pages 520-527

  Fagan, Jennifer L ^a   Bertolli, Jeanne ^a   McNaghten, A D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PRIORITY JOURNAL; REVIEW; UNITED STATES; VIRUS LOAD;

EID: 77955613394     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335491012500406     Document Type: Review

References (55)

1. Department of Health and Human Services (US), Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2009 Dec 1 [cited 2008 Nov 21]. Available from: URL: http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL. pdf
2. Chun TW, Justement JS, Moir S, Hallahan CW, Maenza J, Mullins JI, et al. Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus. J Infect Dis 2007;195:1762-4.
3. Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002;360:119-29.
4. Fisher JD, Cornman DH, Osborn CY, Amico KR, Fisher WA, Friedland GA. Clinician-initiated HIV risk reduction intervention for HIV-positive persons: formative research, acceptability, and fidelity of the Options Project. J Acquir Immune Defic Syndr 2004;37 Suppl 2:S78-87.
5. Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society - USA Panel. Top HIV Med 2006;14:827-43.
6. Hisada M, O'Brien TR, Rosenberg PS, Goedert JJ. Virus load and risk of heterosexual transmission of human immunodeficiency virus and hepatitis C virus by men with hemophilia. The Multicenter Hemophilia Cohort Study. J Infect Dis 2000;181:1475-8.
7. Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000;30 Suppl 1:S5-14.
8. Lalani T, Hicks C. Does antiretroviral therapy prevent HIV transmission to sexual partners? Curr Infect Dis Rep 2008;10:140-5.
9. Lichtenstein K, Armon C, Moorman A, Buchacz K, Brooks J; the HOPS Investigators. Initiation of antiretroviral therapy at higher CD4+ T cell counts reduces incidence of nucleoside analogue toxicities acutely and risk for later development with continued use of these agents in the HIV outpatient (HOPS) cohort. Presented at the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention; 2007 Jul 22-25; Sydney, Australia.
10. McNaghten AD, Hanson DL, Jones JL, Dworkin MS, Ward JW. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. AIDS 1999;13:1687-95.
11. Moore RD, Keruly JC. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis 2007;44:441-6.
12. Palella FJ Jr, Deloria-Knoll M, Chmiel JS, Moorman AC, Wood KC, Greenberg AE, et al. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med 2003;138:620-6.
13. Phillips AN, Gazzard BG, Clumeck N, Losso MH, Lundgren JD. When should antiretroviral therapy for HIV be started? BMJ 2007;334:76-8.
14. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342:921-9.
15. Richardson JL, Milam J, McCutchan A, Stoyanoff S, Bolan R, Weiss J, et al. Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: a multi-clinic assessment. AIDS 2004;18:1179-86.
16. Kamb ML, Fishbein M, Douglas JM Jr, Rhodes F, Rogers J, Bolan G, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. JAMA 1998;280:1161-7.
17. Cheever LW, Lubinski C, Horberg M, Steinberg JL. Ensuring access to treatment for HIV infection. Clin Infect Dis 2007;45 Suppl 4:S266-74.
18. Fleming PL, Byers RH, Sweeney PA, Daniels D, Karon JM, Janssen RS. HIV prevalence in the United States, 2000. Presented at the 9th Conference on Retroviruses and Opportunistic Infections; 2002 Feb 24-28; Seattle. Also available from: URL: http://www.retroconference.org/2002/abstract/13996.htm [cited 2008 Nov 22].
19. Centers for Disease Control and Prevention (US). HIV prevention strategic plan through 2005. January 2001 [cited 2009 Oct 30]. Available from: URL: http://www.cdc.gov/hiv/resources/reports/psp/pdf/prev-strat-plan.pdf
20. Centers for Disease Control and Prevention (US). HIV prevention strategic plan: extended through 2010. October 2007 [cited 2009 Oct 30]. Available from: URL: http://www.cdc.gov/hiv/resources/reports/psp
21. Ryan White CARE Act Amendments of 2000. Public Law 106-345. 106th Congress (2nd session).
22. Health Resources and Services Administration (US). Reauthorization letter on unmet need, 2003 [cited 2008 Nov 22]. Available from: URL: http://hab.hrsa.gov/tools/unmetneed/letter.htm
23. Tobias C, Cunningham WE, Cunningham CO, Pounds MB. Making the connection: the importance of engagement and retention in HIV medical care. AIDS Patient Care STDS 2007;21 Suppl 1:S3-8.
24. Chesney MA, Smith AW. Critical delays in HIV testing and care. Am Behav Sci 1999;42:1162-74.
25. Conviser R, Pounds MB. The role of ancillary services in client-centered systems of care. AIDS Care 2002;14 Suppl 1:S119-31.
26. Cunningham CO, Sohler NL, Korin L, Gao W, Anastos K. HIV status, trust in health care providers, and distrust in the health care system among Bronx women. AIDS Care 2007;19:226-34.
27. Cunningham WE, Andersen RM, Katz MH, Stein MD, Turner BJ, Crystal S, et al. The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States. Med Care 1999;37:1270-81.
28. Gardner LI, Marks G, Metsch LR, Loughlin AM, O'Daniels C, del Rio C, et al. Psychological and behavioral correlates of entering care for HIV infection: the Antiretroviral Treatment Access Study (ARTAS). AIDS Patient Care STDS 2007;21:418-25.
29. Giordano TP, White AC Jr, Sajja P, Graviss EA, Arduino RC, Adu-Oppong A, et al. Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr 2003;32:399-405.
30. Krawczyk CS, Funkhouser E, Kilby JM, Kaslow RA, Bey AK, Vermund SH. Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV/AIDS clinic. South Med J 2006;99:472-81. (Pubitemid 43804516)
31. Lain MA, Valverde M, Frehill LM. Late entry into HIV/AIDS medical care: the importance of past relationships with medical providers. AIDS Care 2007;19:190-4.
32. Meyerson BE, Klinkenberg WD, Perkins DR, Laffoon BT. Who's in and who's out: use of primary medical care among people living with HIV. Am J Public Health 2007;97:744-9.
33. Montoya ID, Trevino RA, Kreitz DL. Access to HIV services by the urban poor. J Community Health 1999;24:331-46.
34. Raveis VH, Siegel K, Gorey E. Factors associated with HIV-infected women's delay in seeking medical care. AIDS Care 1998;10:549-62.
35. Rumptz MH, Tobias C, Rajabiun S, Bradford J, Cabral H, Young R, et al. Factors associated with engaging socially marginalized HIV-positive persons in primary care. AIDS Patient Care STDS 2007;21 Suppl 1:S30-9.
36. Samet JH, Freedberg KA, Stein MD, Lewis R, Savetsky J, Sullivan L, et al. Trillion virion delay: time from testing positive for HIV to presentation for primary care. Arch Intern Med 1998;158:734-40.
37. Shapiro MF, Morton SC, McCaffrey DF, Senterfitt JW, Fleishman JA, Perlman JF, et al. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA 1999;281:2305-15.
38. Hayes C, Gambrell A, Young S, Conviser R. Using data to make decisions: planning HIV/AIDS care under the Ryan White CARE Act. AIDS Educ Prev 2005;17(6 Suppl B):17-25. (Pubitemid 43075980)
39. Ikard K, Janney J, Hsu LC, Isenberg DJ, Scalco MB, Schwarcz S, et al. Estimation of unmet need for HIV primary medical care: a framework and three case studies. AIDS Educ Prev 2005;17(6 Suppl B):26-38. (Pubitemid 43075981)
40. Tobias CR, Cunningham W, Cabral HD, Cunningham CO, Eldred L, Naar-King S, et al. Living with HIV but without medical care: barriers to engagement. AIDS Patient Care STDS 2007;21:426-34.
41. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR Recomm Rep 1999;48(RR-13):1-27, 29-31.
42. Gibson JM, Mokotoff E. Laboratory reporting of clinical test results indicative of HIV infection: new standards for a new era of surveillance and prevention. Council of State and Territorial Epidemiologists Position Statements. 2004 [cited 2008 Nov 22]. Available from: URL: http://www.cste.org/ ps/2004pdf/04-ID-07-final.pdf
43. Glynn MK, Lee LM, McKenna MT. The status of national HIV case surveillance, United States 2006. Public Health Rep 2007;122 (Suppl 1):63-71.
44. Perkins D, Meyerson BE, Klinkenberg D, Laffoon BT. Assessing HIV care and unmet need: eight data bases and a bit of perseverance. AIDS Care 2008;20:318-26.
45. Institute of Medicine, Committee on the Ryan White CARE Act. Measuring what matters: allocation, planning, and quality assessment for the Ryan White CARE Act. Washington: National Academies Press; 2004.
46. Gostin LO, Lazzarini Z, Flaherty KM. Legislative survey of state confidentiality laws, with specific emphasis on HIV and immunization. 2007 [cited 2008 Nov 22]. Available from: URL: http://www.epic.org/privacy/medical/ cdc-survey.html
47. Public Health Service Act. The Public Health and Welfare. U.S.C. Title 42 (2005).
48. Johnson CH, Bertolli J, Reed JB; the Never in Care project. Identifying and interviewing persons with a recent HIV diagnosis not yet receiving medical care. In: JSM [Joint Statistical Meetings] Proceedings, Section on Statistics in Epidemiology. Alexandria (VA): American Statistical Association; 2008. p. 601-8.
49. McNaghten AD, Wolfe MI, Onorato I, Nakashima AK, Valdiserri RO, Mokotoff E, et al. Improving the representativeness of behavioral and clinical surveillance for persons with HIV in the United States: the rationale for developing a population-based approach. PloS ONE 2007;2:e550.
50. Advancing HIV prevention: new strategies for a changing epidemic - United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52(15):329-32.
51. Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006;55(RR-14):1-17.
52. Revised guidelines for HIV counseling, testing, and referral and revised recommendations for HIV screening of pregnant women. MMWR Recomm Rep 2001;50(RR-19):1-39.
53. Saag MS. Opt-out testing: who can afford to take care of patients with newly diagnosed HIV infection? Clin Infect Dis 2007;45 Suppl 4:S261-5.
54. Institute of Medicine. Unequal treatment: confronting racial and ethnic disparities in health care. Washington: National Academies Press; 2003.
55. Lee LM, McKenna MT. Monitoring the incidence of HIV infection in the United States. Public Health Rep 2007;122 Suppl 1:72-9.